Close Menu
    What's Hot

    Cancer Research UK Pension Scheme Completes Bulk Purchase Annuity Buy-In With Standard Life

    12 May 2025

    AQA Education Completes Bulk Purchase Annuity Buy-In With Rothesay

    12 May 2025

    Obra Capital Promotes Peter Polanskyj to Chief Investment Officer

    12 May 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Life Insurer Credit Risk in the News Again but Life Settlement Market Keeps On Keeping On

      10 April 2025

      Capital-Backed Journey Plans Re-Enter Defined Benefit Pension De-Risking Debate as New Rules Loom

      10 April 2025

      Understanding the Impact of Covid-19 on Future Mortality Remains an Almost Impossible Task

      10 April 2025

      Canadian Pension Risk Transfer Market Set To Establish Higher Floor as Aggregate Deal Value Surges

      10 April 2025

      Q&A: Martin Kramer, Managing Partner, Ceptar Consulting

      10 April 2025
    • Commentary

      Could Climate Change Cause the Buy-In Market To Collapse?

      10 April 2025

      ICS vs Solvency II: Comparing Risk Corrections for Illiquid Liabilities

      10 April 2025

      Falls: Significance in Life Expectancy Underwriting

      13 March 2025

      Spotlight on Longevity Capital Models

      13 March 2025

      Bulk Annuities: Who Steers the Ship?

      12 February 2025
    • Events
    • Magazine
    • News

      Cancer Research UK Pension Scheme Completes Bulk Purchase Annuity Buy-In With Standard Life

      12 May 2025

      AQA Education Completes Bulk Purchase Annuity Buy-In With Rothesay

      12 May 2025

      Obra Capital Promotes Peter Polanskyj to Chief Investment Officer

      12 May 2025

      Universal Life Insurance Applications Grows for ages 61+ in April

      12 May 2025

      Competitive Pension Risk Transfer Cost Climbs to in March

      30 April 2025
    Subscribe
    Life Risk News
    Home » How Many More Asset Managers Can the US Pension Risk Transfer Market Absorb?

    How Many More Asset Managers Can the US Pension Risk Transfer Market Absorb?

    Features 12 February 2025Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    The increasing role – and influence – of ‘private equity’ firms in the US pension risk transfer (PRT) market in recent years has caught the attention of the media, regulators, and litigators, as questions have arisen about the suitability of the private investments that these firms make as the assets that they invest in underpin literally millions of American retirees’ pensions. 

    Only that ‘private equity’ is not really the correct term to use. Whilst firms in the space such as Apollo (which has merged with insurance company Athene), Blackstone and KKR might have got their start in the leveraged buyout world, these firms are now multi-asset managers, and listed companies, so the terminology is wrong for starters. 

    ‘Asset managers’ is closer to correct. But terminology aside, what is the reality of more of these firms coming into the US PRT market? After all, in the primary market – defined benefit (DB) pension to insurer – there were 21 insurance companies writing business as of December last year, according to WTW. On the surface, numbers-wise, that would seem like a competitive field (at least compared to the UK, where there were only ten at press time). 

    So, if you’re an asset manager looking at buying an insurer now, are you too late? 

    “From the pension plan perspective, there is still room for more insurers. On a given deal you don’t often see more than five, six or so bidding as insurers operate at different ends of the market,” said James Walton, Managing Director at consultants Agilis. 

    “We see PRT market growth in the US as robust – growing by double digits, as strong equity returns, and interest rate rises of recent years are likely to spur further pension plans to transact in coming years. If you’re talking about coming in and taking a 20% share then I think those day are gone, but I don’t see why a few more insurers couldn’t enter and pick up some share that’s enough to justify entering – but any new insurer would be required to have some kind of pricing edge if they are to compete in the market,” Walton added. 

    That pricing edge depends on the ability of the insurer to generate returns on the underlying assets. The greater the return, the lower the premium they can charge to the defined benefit pension scheme, other things being equal. And one of the ways that insurers differentiate themselves is through access to private market opportunities, whether that be through an affiliate or wholly owned asset manager, or whether the arrangement is through some kind of partnership. 

    The regulatory burden placed on life insurers in the US, while strong, is arguably less onerous than those placed by the Solvency II (S2) regime in the EU. Even the UK’s adjustments to the regulation – Solvency UK – has maintained many of the original features of S2, the result of which means that a significant amount of the assets backing schemes across the pond are more liquid fixed income, such as government and corporate bonds. Whilst private assets still make it onto the balance sheet of life insurers in Europe, there is more scope for these opportunities stateside, which is what is driving the increased participation from asset management firms. 

    “The involvement of asset managers in insurance to date has been about utilizing their investment capabilities in forms of private credit and structured credit. Insurers in the US generally don’t need help with public bonds as they have their own teams already for this. But they don’t always have a competitive advantage in private asset opportunities. Any new entrant would likely need these capabilities in order to be successful,” said Walton. 

    The term ‘private equity’ is arguably more a political term these days. Indeed, the SECURE 2.0 Act of 2022, which came into law in late December of that year, directed the Department of Labor to review the Employee Benefits Security Administration’s Interpretive Bulletin 95-1 ‘to determine whether amendments to Interpretive Bulletin 95-1 are warranted.’ The report, published in June last year, uses the term ‘private equity’ 54 times. 

    IB 95-1 is a foundational regulatory pillar of the US market as it states that DB schemes transacting with an insurer must use the ‘safest annuity available’, and lawsuits have been filed against plan sponsors that claim otherwise. 

    Just recently, the ERISA Industry Committee (ERIC) and coalition allies (the amici) filed an amicus brief in the US District Court of the Southern District of New York to dismiss Doherty v. Bristol-Myers Squibb (Doherty). In its brief, the amici asserted that the plaintiffs lack standing and argued there was no viable claim for relief. 

    “Like the 401(k) fee class actions that came before them, this new wave of pension risk transfer litigation appears to be the next proverbial pot of gold for the plaintiffs’ bar,” said Tom Christina, Executive Director of the ERIC Legal Center.  

    “If meritless claims like this advance beyond swift dismissal, there is significant risk the floodgates will burst open, and plaintiffs’ firms will get a big payday while employers and employees will be faced with big legal bills and an even bigger threat to the retirement system we know today. This would be devastating to plan sponsors and, in turn, to the participants who rely on them for jobs and benefits.” 

    Market participants will likely be keeping a close eye on any developments here. But regardless of the outcome and the potential impact of the outcome, for Walton, there is still scope for more asset managers to enter the market. 

    “It is important to remember that only around 10% of the entire universe of DB schemes in the US has transacted so far,” he said. 

    “As I said, any new entrant will likely need some kind of pricing edge. But, thanks to the macroeconomic environment of the past few years, combined in many cases with contributions paid into plans, there are an enormous amount of US DB plans that will be looking to transact. I’ve seen some insurers turn away bids because they were simply too busy working on other deals. There is room for more insurers, but they will have to differentiate their offering and have reasonable expectations around overall volume.”

    2025 - February Longevity and Mortality Risk Transfer Longevity Risk Pension Risk Transfer Volume 4 Issue 2 - February 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Life Insurer Credit Risk in the News Again but Life Settlement Market Keeps On Keeping On

    10 April 2025

    Capital-Backed Journey Plans Re-Enter Defined Benefit Pension De-Risking Debate as New Rules Loom

    10 April 2025

    Understanding the Impact of Covid-19 on Future Mortality Remains an Almost Impossible Task

    10 April 2025

    Canadian Pension Risk Transfer Market Set To Establish Higher Floor as Aggregate Deal Value Surges

    10 April 2025

    Comments are closed.

    Most Popular

    Life Insurer Credit Risk in the News Again but Life Settlement Market Keeps On Keeping On

    10 April 2025

    Capital-Backed Journey Plans Re-Enter Defined Benefit Pension De-Risking Debate as New Rules Loom

    10 April 2025

    Understanding the Impact of Covid-19 on Future Mortality Remains an Almost Impossible Task

    10 April 2025

    Canadian Pension Risk Transfer Market Set To Establish Higher Floor as Aggregate Deal Value Surges

    10 April 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT